医生对临床决策支持的看法,以治疗ED中心力衰竭患者
Scott D Casey1,2, Mary E Reed1,2, Chris LeMaster3
1Kaiser Permanente Division of Research, Oakland, California.
JAMA network open
|November 21, 2023
概括
紧急部门的医生发现临床决策支持 (CDS) 对心力衰竭 (HF) 治疗有帮助,但建议改善可用性和工作流集成. 他们更喜欢被动提示而不是强制性警报,以提高采用率.
科学领域:
- 医疗信息学 医疗信息学
- 临床决策支持系统 临床决策支持系统
- 紧急医疗 紧急医疗
背景情况:
- 临床决策支持 (CDS) 系统为急诊室 (ED) 医生管理心力衰竭 (HF) 患者提供了潜在的好处.
- 医生的观点对于在临床实践中有效设计和实施CDS工具至关重要.
研究的目的:
- 从ED医生最终用户的角度评估新型CDS工具的可用性和工作流集成.
- 确定障碍物和促进者,以在ED环境中成功实施CDS.
主要方法:
- 一项混合方法的定性研究,涉及与ED医生进行半结构面试.
- 基于可用性启发式和社会技术模型的电子调查的开发.
- 从两个社区急救中心的医生收集数据,试点进行CDS干预.
主要成果:
- 医生认为CDS对患者护理有益,但建议对可访问性,功能和工作流集成进行改进.
- 工作负担的担忧影响了医生愿意始终遵守CDS建议的意愿.
- 他们更喜欢鼓励互动的被动提示,而不是强制性警报.
结论:
- 有机会优化CDS的可用性和在ED工作流程中的集成,以对急性心力衰竭进行管理.
- 解决医生对工作量和交互偏好的担忧是成功实施CDS的关键.
- 医生反对于改进CDS工具以有效支持临床决策至关重要.
更多相关视频
相关概念视频
Heart Failure Drugs: Diuretics
398
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
398
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
436
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
436
Heart Failure Drugs: β-Blockers
344
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
344
Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
Heart Failure Drugs: Inotropic Agents
596
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
596
Ethical Issues
978
Nurses are essential in patient care, upholding the ethical principles of their profession and effectively navigating ethical dilemmas. Neglecting ethical issues can lead to inadequate patient care, compromised therapeutic relationships, and moral distress among healthcare workers.
Ethical Concerns in Healthcare:
Ethical Concerns in Healthcare:
978


